Absence of maternal-fetal transmission of human immunodeficiency virus type 1 to second-trimester fetuses

Am J Obstet Gynecol. 2000 Sep;183(3):638-42. doi: 10.1067/mob.2000.106591.

Abstract

Objective: The aim of this study was to evaluate the contribution of in utero infection to the vertical transmission of human immunodeficiency virus type 1 during the second trimester.

Study design: We examined fetal tissues from 21 second-trimester prostaglandin-induced abortions among human immunodeficiency virus type 1-infected women and compared the fetal vertical transmission rates with those among children born to human immunodeficiency virus-seropositive women. The presence of human immunodeficiency virus type 1 nucleic acid sequences was investigated with two different highly sensitive polymerase chain reaction techniques in tissue samples from the fetal thymus, lung, and brain.

Results: No human immunodeficiency virus type 1 deoxyribonucleic acid was detected in any of the samples.

Conclusion: The absence of human immunodeficiency virus type 1 in all fetuses in our study is compatible with a low rate of maternal-fetal transmission during the second trimester of pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / prevention & control
  • Acquired Immunodeficiency Syndrome / transmission*
  • Adult
  • CD4 Lymphocyte Count
  • Female
  • Gestational Age*
  • HIV-1 / genetics
  • Humans
  • Infectious Disease Transmission, Vertical*
  • Pregnancy
  • Prospective Studies
  • RNA, Viral / blood
  • Zidovudine / therapeutic use

Substances

  • RNA, Viral
  • Zidovudine